• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • News
  • QMS/PMS

News


  • Moments
  • Regulations & Guidelines
  • Fast Track Update
  • QMS/PMS
  • Other News
  • NMPA Monthly Newsletter
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021

NMPA AE And Recall Report In October 2021

2021-12-02

In October, 2021, NMPA published the AE and recall list reported by overseas manufacturers. Since China NMPA enhances…

NMPA AE And Recall Report In September 2021

2021-12-02

In September, 2021, NMPA published the AE and recall list reported by overseas manufacturers. Since China NMPA enhances…

New NMPA Review Guideline Of Animal Studies For Medical Device Registration

2021-11-27

On Sep 27, 2021, NMPA published a new Review Guideline of Animal Studies for Medical Device Registration: Part…

New E-filing Catalogue For Medical Device Registration Effective Since Jan 1, 2022

2021-11-17

According to the Regulations on Supervision and Administration of Medical devices (Order 739), the Administrative Measures for Registration…

China NMPA Newsletter – October 2021

2021-11-17

Inspirative Medical - A BradyKnows Company October 2021 China NMPA Newsletter Official Publication of BradyKnows Official NMPA Regulation…

New China GCP To Be Issued Soon

2021-11-10

As a member of IMDRF (International Medical Device Regulators Forum), China is actively leading and participating in the…

New Requirements For Medical Device And IVD Registration Application Dossiers

2021-11-03

More and more new guidelines are published according to the Regulations on Supervision and Administration of Medical devices…

Official NMPA Regulation Released: Self-Testing For Medical Device Registration In China

2021-10-27

Fundamental of Type Testing Type testing, also known as medical device registration testing, is a mandatory requirement by…

UDI Mandatory For Class III Medical Devices In China After June 1st, 2022!

2021-10-19

Recently, NMPA issued an announcement on the implementation of the second batch of Unique Device Identification (UDI) of…

Approval For Innovative Electron Linear Accelerator

2021-10-18

Recently, NMPA approved the registration application of the innovative electronic linear accelerator produced by Linatech in Suzhou, China.…

Key Points Worth Noting Under The New Registration And Filing Regulations For Medical Devices And IVD

2021-09-30

The Provisions for Medical Device Registration and Filing and the Provisions for In-vitro Diagnostic Reagent Registration and Filing…

Inventory Of Guidelines In September

2021-09-29

On September 28, 2021, NMPA issued a notice of five technical guidelines including Technical Guidelines for Clinical Evaluation…
« Prev...246...1213141516...Next »
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7